-
2
-
-
33846449510
-
Management of recurrent testicular germ cell tumors
-
DOI 10.1634/theoncologist.12-1-51
-
Sonpavde G, Hutson TE, Roth BJ. Management of recurrent testicular germ cell tumors. Oncologist 2007 12 : 51 61. (Pubitemid 46143502)
-
(2007)
Oncologist
, vol.12
, Issue.1
, pp. 51-61
-
-
Sonpavde, G.1
Hutson, T.E.2
Roth, B.J.3
-
3
-
-
20344396588
-
Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours
-
DOI 10.1016/j.ctrv.2005.02.001, PII S0305737205000290
-
El-Helw L, Coleman RE. Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours. Cancer Treat. Rev. 2005 31 : 197 209. (Pubitemid 40790391)
-
(2005)
Cancer Treatment Reviews
, vol.31
, Issue.3
, pp. 197-209
-
-
El-Helw, L.1
Coleman, R.E.2
-
4
-
-
23944440892
-
Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors
-
DOI 10.1016/j.eururo.2005.04.024, PII S0302283805002691
-
Farmakis D, Pectasides M, Pectasides D. Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors. Eur. Urol. 2005 48 : 400 7. (Pubitemid 41188394)
-
(2005)
European Urology
, vol.48
, Issue.3
, pp. 400-407
-
-
Farmakis, D.1
Pectasides, M.2
Pectasides, D.3
-
5
-
-
25144455744
-
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
-
DOI 10.1093/annonc/mdi228
-
Pico JL, Rosti G, Kramar A et al. A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann. Oncol. 2005 16 : 1152 9. (Pubitemid 41418319)
-
(2005)
Annals of Oncology
, vol.16
, Issue.7
, pp. 1152-1159
-
-
Pico, J.-L.1
Rosti, G.2
Kramar, A.3
Wandt, H.4
Koza, V.5
Salvioni, R.6
Theodore, C.7
Lelli, G.8
Siegert, W.9
Horwich, A.10
Marangolo, M.11
Linkesch, W.12
Pizzocaro, G.13
Schmoll, H.-J.14
Bouzy, J.15
Droz, J.-P.16
Biron, P.17
-
6
-
-
33749006844
-
Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: A single-institute experience
-
DOI 10.1097/01.cad.0000231469.46664.12, PII 0000181320061000000008
-
Hara I, Miyake H, Yamada Y et al. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience. Anticancer Drugs 2006 17 : 1057 66. (Pubitemid 44454783)
-
(2006)
Anti-Cancer Drugs
, vol.17
, Issue.9
, pp. 1057-1066
-
-
Hara, I.1
Miyake, H.2
Yamada, Y.3
Yamanaka, K.4
Furukawa, J.5
Kumano, M.6
Takenaka, A.7
Fujisawa, M.8
-
7
-
-
34247573579
-
First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors
-
DOI 10.1111/j.1442-2042.2006.01718.x
-
Kumano M, Miyake H, Hara I, Furukawa J, Takenaka A, Fujisawa M. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors. Int. J. Urol. 2007 14 : 336 8. (Pubitemid 46669050)
-
(2007)
International Journal of Urology
, vol.14
, Issue.4
, pp. 336-338
-
-
Kumano, M.1
Miyake, H.2
Hara, I.3
Furukawa, J.4
Takenaka, A.5
Fujisawa, M.6
-
8
-
-
0346035001
-
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support
-
DOI 10.1016/S0959-8049(03)00003-0, PII S0959804903000030
-
Kollmannsberger C, Schleucher N, Rick O et al. Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support. Eur. J. Cancer 2003 39 : 775 82. (Pubitemid 36315994)
-
(2003)
European Journal of Cancer
, vol.39
, Issue.6
, pp. 775-782
-
-
Kollmannsberger, C.1
Schleucher, N.2
Rick, O.3
Metzner, B.4
Hartmann, J.T.5
Schoffski, P.6
Beyer, J.7
Casper, J.8
Sosada, M.9
Schmoll, H.-J.10
Bohlke, I.11
Meisner, C.12
Kanz, L.13
Bokemeyer, C.14
-
9
-
-
33644842476
-
Recent advances in management of patients with platinum-refractory testicular germ cell tumors
-
DOI 10.1002/cncr.21742
-
Kollmannsberger C, Nichols C, Bokemeyer C. Recent advances in management of patients with platinum-refractory testicular germ cell tumors. Cancer 2006 106 : 1217 26. (Pubitemid 43363897)
-
(2006)
Cancer
, vol.106
, Issue.6
, pp. 1217-1226
-
-
Kollmannsberger, C.1
Nichols, C.2
Bokemeyer, C.3
-
10
-
-
0034090454
-
Persistent gestational trophoblastic disease: Results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease
-
Dobson LS, Lorigan PC, Coleman RE, Hancock BW. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease. Br. J. Cancer 2000 82 : 1547 52.
-
(2000)
Br. J. Cancer
, vol.82
, pp. 1547-52
-
-
Dobson, L.S.1
Lorigan, P.C.2
Coleman, R.E.3
Hancock, B.W.4
-
11
-
-
0033938650
-
Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors
-
DOI 10.1006/gyno.2000.5813
-
Matsui H, Suzuka K, Iitsuka Y, Seki K, Sekiya S. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. Gynecol. Oncol. 2000 78 : 28 31. (Pubitemid 30439474)
-
(2000)
Gynecologic Oncology
, vol.78
, Issue.1
, pp. 28-31
-
-
Matsui, H.1
Suzuka, K.2
Iitsuka, Y.3
Seki, K.4
Sekiya, S.5
-
13
-
-
0031037241
-
International germ cell consensus classification: A prognostic factor- based staging system for metastatic germ cell cancers
-
International Germ Cell Cancer Collaborative Group (IGCCCG). The International Germ Cell Cancer Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancer. J. Clin. Oncol. 1997 15 : 594 603. (Pubitemid 27074227)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.2
, pp. 594-603
-
-
Mead, G.M.1
-
14
-
-
0141923872
-
Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers
-
DOI 10.1002/cncr.11711
-
Habuchi T, Kamoto T, Hara I et al. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers. Cancer 2003 98 : 1635 42. (Pubitemid 37238619)
-
(2003)
Cancer
, vol.98
, Issue.8
, pp. 1635-1642
-
-
Habuchi, T.1
Kamoto, T.2
Hara, I.3
Kawai, K.4
Nakao, M.5
Nonomura, N.6
Kobayashi, T.7
Ogawa, O.8
Kamidono, S.9
Akaza, H.10
Okuyama, A.11
Kato, T.12
Miki, T.13
-
15
-
-
1642357541
-
Histology in mixed germ cell tumors. Is there a favorite pairing?
-
Mosharafa AA, Foster RS, Leibovich BC et al. Histology in mixed germ cell tumors. Is there a favorite pairing? J. Urol. 2004 171 : 147 3.
-
(2004)
J. Urol.
, vol.171
, pp. 147-3
-
-
Mosharafa, A.A.1
Foster, R.S.2
Leibovich, B.C.3
-
16
-
-
0032828119
-
Classification and pathology of testicular germ cell and sex cord- stromal tumors
-
DOI 10.1016/S0094-0143(05)70201-9
-
Cheville JC. Classification and pathology of testicular germ cell and sex cord-stromal tumors. Urol. Clin. North Am. 1999 26 : 595 609. (Pubitemid 29411685)
-
(1999)
Urologic Clinics of North America
, vol.26
, Issue.3
, pp. 595-609
-
-
Cheville, J.C.1
-
17
-
-
69049099940
-
The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines
-
Perry J, Powles T, Shamash J et al. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines. Cancer Chemother. Pharmacol. 2009 64 : 925 33.
-
(2009)
Cancer Chemother. Pharmacol.
, vol.64
, pp. 925-33
-
-
Perry, J.1
Powles, T.2
Shamash, J.3
-
18
-
-
67349189170
-
Why doesn't high-dose chemotherapy improve survival, as was expected, in advanced or relapsed germ cell tumours?
-
Pizzocaro G, Guarneri A. Why doesn't high-dose chemotherapy improve survival, as was expected, in advanced or relapsed germ cell tumours? Eur. Urol. 2009 56 : 46 7.
-
(2009)
Eur. Urol.
, vol.56
, pp. 46-7
-
-
Pizzocaro, G.1
Guarneri, A.2
-
19
-
-
37349084288
-
Postchemotherapy Retroperitoneal Lymph Node Dissection in Advanced Germ Cell Tumours of the Testis
-
DOI 10.1016/j.eururo.2007.10.033, PII S0302283807013450
-
Heidenreich A, Thüer D, Polyakov S. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis. Eur. Urol. 2008 53 : 260 72. (Pubitemid 350296590)
-
(2008)
European Urology
, vol.53
, Issue.2
, pp. 260-274
-
-
Heidenreich, A.1
Thuer, D.2
Polyakov, S.3
|